Biosimilars are medications that are highly similar to U.S. Food and Drug Administration (FDA)-approved reference biologics – the fastest-growing class of drugs in the U.S., bringing innovative, life-changing treatments to patients…
Novartis today announced that it has completed its acquisition of Chinook Therapeutics, Inc., a Seattle, WA, based biopharmaceutical company focused on the discovery, development, and commercialization of precision medicines for…
Novartis today announced positive top-line results from the Phase III REMIX-1 and REMIX-2 studies evaluating remibrutinib 25 mg b.i.d., a Bruton’s tyrosine kinase (BTK) inhibitor, in patients with chronic spontaneous…
The 2022 Kaiser Permanente Southern California Community Health Snapshot highlights our commitment to enhancing community health by addressing social factors that influence well-being and expanding access to care. In 2022, Kaiser Permanente…
Aetna Better Health® of Georgia, a CVS Health® company (NYSE: CVS), announced that Aetna® has provided a community investment of $40,000 to March of Dimes. The investment will contribute to a…
Aetna Better Health® of Kansas today announced that Aetna® has donated $30,000 to Oral Health Kansas, Inc., to help support its Pathways to Oral Health: Education Initiatives for Accessible Dental Care…
Elevance Health (NYSE: ELV) announced today that John Gallina will retire from his role as executive vice president and CFO later this year. Mark Kaye has been named executive vice president and…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for ERVEBO,…
Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 40-cents per share on the Company’s capital stock, payable on September 5, 2023, to shareholders of record…
Home hemodialysis (HHD) and peritoneal dialysis (PD) are both performed at home by the patient, often with the aid of a trained care partner or family member. Both treatments can offer individuals more…
Chicagoans face a dual threat of deadly heat and unhealthy air Friday, expected to be the hottest day so far this year. Forecasters predict a heat index — a measure…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the pivotal Phase 3 KEYNOTE-756 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with…